It has been show that HGF can induce tyrosine-kinase inhibitors resistance in lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) mutations, presumably through cross-talk activation of the PI3K/AKT pathway [62,63]. Here, EGFR is linked to lung adenocarcinoma.